Fiche centre
The Affiliated Hospital of Xuzhou Medical University
Xuzhou — China
Essais liés12clinical trials
VilleXuzhoulocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07875179
Essais cliniques associés
12| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Recombinant staphylokinase | Maladie coronarienne | Phase 4 | NCT05410925 | OPTIMA-6 — Efficacy and Safety of a Half-dose Bolus of r-SAK Prior to Primary PCI in ST-elevation Myocardial Infarction | RECRUITING |
| IMPT-514 CART Cell Injection | SEP | Phase 1 | NCT06462144 | IMPT-514 in Systemic Lupus Erythematosus, Anca-associated Vasculitis, and Idiopathic Inflammatory Myopathy | TERMINATED |
| Early anticoagulation | Accident vasculaire cérébral | Non applicable | NCT07139314 | TIMERS-2 — Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation 2 | RECRUITING |
| Anisodine Hydrobromide | Accident vasculaire cérébral | Phase 2 | NCT07800572 | Anisodine Hydrobromide for Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy (HEAL-2) | RECRUITING |
| Recombinant Streptokinase | Maladie coronarienne | Phase 4 | NCT07875179 | IMPROVE-STEMI: pPCI Plus Low-dose r-SK in STEMI | NOT_YET_RECRUITING |
| Giredestrant | Cancer | Phase 3 | NCT06065748 | A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer) | ACTIVE_NOT_RECRUITING |
| IPG11406 | Lupus | Phase 1/2 | NCT06717815 | Phase IIa Study for IPG11406 in Patients With Lupus Nephritis | COMPLETED |
| obinutuzumab (RO5072759) | Lupus | Phase 3 | NCT07767188 | A Trial to Explore the Efficacy and Safety of O-triple as Initial Therapy in the Active Lupus Nephritis Patients (INITIAL Trial) | NOT_YET_RECRUITING |
| HN2302 Injection | Myasthénie | Non applicable | NCT07413835 | Efficacy and Safety of HN2302 in Refractory Myasthenia Gravis(MG) | RECRUITING |
| Trontinemab | Alzheimer | Phase 3 | NCT07169578 | TRONTIER 1 — A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease | ACTIVE_NOT_RECRUITING |
| Prasinezumab | Parkinson | Phase 3 | NCT07174310 | PARAISO — A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease | RECRUITING |
| UCAR-T cells | Lupus | NA | NCT07155369 | UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases | ACTIVE_NOT_RECRUITING |